ERBB2 and breast carcinoma: Intravenous injection of HER2-specific NK-92-scFv (FRP5) zeta cell line, in early tumor developmental stages before BBB disruption, using MRI-guided focused-ultrasound combined with MB local irradiation to the tumor inhibited tumor growth in metastatic breast cancer model by amplifying HER2.